Study to Evaluate 5-ALA Combined With CV01 Delivery of Ultrasound in Recurrent High Grade Glioma
Phase 1
Active, not recruiting
- Conditions
- High Grade Glioma
- Interventions
- Drug: 5 Aminolevulinic AcidDevice: CV01-delivered ultrasound
- First Posted Date
- 2022-05-05
- Last Posted Date
- 2025-01-13
- Lead Sponsor
- Alpheus Medical, Inc.
- Target Recruit Count
- 22
- Registration Number
- NCT05362409
- Locations
- 🇺🇸
Washington University School of Medicine in St.Louis, Saint Louis, Missouri, United States
🇺🇸Dent Neurosciences Research Center, Amherst, New York, United States
🇺🇸Northwell, Lake Success, New York, United States
© Copyright 2025. All Rights Reserved by MedPath